Currently, out of the existing stock ratings of Frank Takkinen - 46 which are a Buy (97.87%), 1 which are a Hold (2.13%)

Frank Takkinen

Work Performance Price Targets & Ratings Chart

Analyst Frank Takkinen works at LAKE STREET and is covering the Healthcare sector with 95 price targets and ratings displayed on 14 stocks.

Frank Takkinen's average stock forecast success ratio is 27.52% with an average time for price targets to be met of 53 days.

Most recent stock forecast was given on INSP, Inspire Medical Systems at 02-Aug-2023.

Wall Street Analyst Frank Takkinen

Analyst best performing recommendations are on UPH.
The best stock recommendation documented was for OSUR (ORASURE TECHNOLOGIES) at 6/25/2020. The price target of $19 was fulfilled within 39 days with a profit of $8.19 (75.76%) receiving and performance score of 19.43.

Average potential price target upside

INSP Inspire Medical Systems NOTV OSUR OraSure Technologies STXS SNCE APEN Apollo Endosurgery SLHG UPH AORT PAVM PAVmed BTCY EDAP ICAD PROF Profound Medical

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

322

$123.56 (62.27%)

300

24 days ago

12/13 (92.31%)

$40.58 (23.35%)

234

Buy

340

$141.56 (71.34%)

363

1 months 6 days ago

18/22 (81.82%)

$48.13 (25.18%)

215

Buy

350

$151.56 (76.38%)

305

1 months 28 days ago

9/10 (90%)

$42.7 (21.54%)

146

Buy

340

$141.56 (71.34%)

300

1 months 28 days ago

2/3 (66.67%)

$38.16 (16.69%)

71

Buy

350

$151.56 (76.38%)

300

2 months 17 days ago

5/6 (83.33%)

$35.83 (22.60%)

43

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Frank Takkinen is most bullish on?

Potential upside of $151.56 has been obtained for INSP (INSPIRE MEDICAL SYSTEMS)

Which stock is Frank Takkinen is most reserved on?

Potential downside of $2.89 has been obtained for ICAD

What Year was the first public recommendation made by Frank Takkinen?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart